2011 Blogging Funding Research 
Xconomy
JANUARY 7, 2020
When a group of scientists from Amira Pharmaceuticals wanted to start a new biotech after the company’s 2011 acquisition by Bristol-Myers Squibb , Celgene provided seed funding.
Xconomy
OCTOBER 13, 2017
The idea in 2011 was to create a space at what was then Johnson & Johnson’s pharmaceutical research and development facility in San Diego for an “innovation center,” a place where 18 to 20 life sciences startups could incubate, replete with lab space and equipment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
JANUARY 14, 2014
It’s why the first company I ever invested in as a VC – Invoca – just announced a $20 million funding by Accel Partners. The three largest webmail services had over 1 billion global users at the end of 2011. I suppose I could have skipped the whole rest of the blog post and just posted that. THE FULL STORY.
Tech Zulu Event
FEBRUARY 21, 2014
Since the official YC announcement and launch of their crowdfunding campaign, they’ve successfully raised an initial goal of $482,000; to fund a final immunization experiments before undergoing Phase I clinical studies. As of 2011, the annual death toll for AIDS-related mortalities was estimated to be 1.7 The Eventual Goal?
Xconomy
OCTOBER 18, 2016
Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. In three years, Vertex went from having a billion-dollar hepatitis C business to zero—abandoning the research completely. Yet it wasn’t a fatal blow.
SoCal Delicious
AUGUST 28, 2012
MYTH 2: Silicon Valley companies will always have the best shot at funding. MYTH 4: Research institutions are stronger in NorCal. Arguably the greatest research and development nexus in the United States rests in the area spanning San Diego to Los Angeles. billion for its endowment in 2011 alone. Editor’s picks.
Xconomy
NOVEMBER 1, 2016
The company inked a partnership with French firm Servier on a heart failure microRNA drug and a few other cardiovascular programs in 2011. That’ll leave the combined company with over $50 million in cash at the deal’s closing. Miragen was formed in 2007 and raised an $8 million Series A round from Atlas and Boulder a year later.
Expert insights. Personalized for you.
63 
Let's personalize your content